Zacks Investment Research downgraded PerkinElmer, Inc. (NYSE:PKI) to Sell in a report released today.
- Updated: October 17, 2016
Just yesterday PerkinElmer, Inc. (NYSE:PKI) traded -0.58% lower at $51.84. PerkinElmer, Inc.’s 50-day moving average is $54.19 and its 200-day moving average is $53.64. The last stock price is down -3.40% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 672,130 shares of PKI traded hands, up from an average trading volume of 523,040
Zacks Investment Research has downgraded PerkinElmer, Inc. (NYSE:PKI) to Sell in a report released on Monday October 17, 2016.
Previously on 10/4/2016, Zacks Investment Research released a statement about PerkinElmer, Inc. (NYSE:PKI) increased the target price from $0.00 to $62.00. At the time, this indicated a possible upside of 0.11%.
Recent Performance Chart
PerkinElmer, Inc. has 52 week low of $39.50 and a 52 week high of $57.28 with a PE ratio of 24.75 and has a market capitalization of $0.
In addition to Zacks Investment Research reporting its stock price target, a total of 17 brokerages have issued a ratings update on the company. The average stock price target is $51.88 with 4 brokerages rating the stock a strong buy, 5 brokerages rating the stock a buy, 9 brokerages rating the stock a hold, 2 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
Brief Synopsis On PerkinElmer, Inc. (NYSE:PKI)
PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The Company's operating segments include Human Health, Environmental Health and Corporate. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier. Within its Human Health segment, the Company serves the diagnostics and research markets. It provides early detection for genetic disorders from pregnancy to early childhood, as well as flat panel X-ray detectors and infectious disease testing for the diagnostics market. The Environmental Health segment provides products, services and solutions to facilitate the creation of safer food and consumer products, secure surroundings and energy resources. The Environmental Health segment serves the environmental, industrial and laboratory services markets. The Company markets its products and services in over 150 countries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.